TARGETING FLT3 WITH CHIMERIC ANTIGEN RECEPTOR T CELLS CONFERS POTENT REACTIVITY AGAINST ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Jetani, H. [1 ]
Garcia-Cadenas, I. [2 ]
Nerreter, T. [1 ]
Sierra, J. [2 ]
Herr, W. [3 ]
Thomas, S. [3 ]
Einsele, H. [1 ]
Hudecek, M. [1 ]
机构：
[1] Univ Hosp Wurzburg, Internal Med 2, Wurzburg, Germany
[2] Hosp Santa Creu & Sant Pau, Serv Hematol, Barcelona, Spain
[3] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 3, Regensburg, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S145
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] FLT3 Inhibitors for Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 573 - 575
  • [32] FLT3 inhibitors in acute myeloid leukemia
    Pastore, Domenico
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 14 - 21
  • [33] FLT3 inhibitors in acute myeloid leukemia
    el-Shami, Khaled
    Stone, Richard M.
    Smith, B. Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 153 - 160
  • [34] Therapeutic Targeting of Mesothelin in Acute Myeloid Leukemia with Chimeric Antigen Receptor T Cell Therapy
    Quy Le
    Castro, Sommer
    Tang, Thao T.
    Loeb, Anisha
    Leonti, Amanda R.
    Pardo, Laura
    Loken, Michael R.
    Correnti, Colin
    Meshinchi, Soheil
    BLOOD, 2020, 136
  • [35] CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
    S S Kenderian
    M Ruella
    O Shestova
    M Klichinsky
    V Aikawa
    J J D Morrissette
    J Scholler
    D Song
    D L Porter
    M Carroll
    C H June
    S Gill
    Leukemia, 2015, 29 : 1637 - 1647
  • [36] CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
    Kenderian, S. S.
    Ruella, M.
    Shestova, O.
    Klichinsky, M.
    Aikawa, V.
    Morrissette, J. J. D.
    Scholler, J.
    Song, D.
    Porter, D. L.
    Carroll, M.
    June, C. H.
    Gill, S.
    LEUKEMIA, 2015, 29 (08) : 1637 - 1647
  • [37] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
    Cartellieri, Marc
    Michalk, Irene
    von Bonin, Malte
    Krueger, Thomas
    Stamova, Slava
    Koristka, Stefanie
    Arndt, Claudia
    Feldmann, Anja
    Schmitz, Marc
    Wermke, Martin
    Lindemann, Dirk
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Bachmann, Michael
    BLOOD, 2011, 118 (21) : 1124 - 1125
  • [38] Implementing RNAi Therapy Targeting FLT3 in Acute Myeloid Leukemia (AML)
    Ansari, Aysha
    Bahadur, Remant K. C.
    Nasrullah, Mohammad
    Sundaram, Daniel N. M.
    Burbano, Luis Morales
    Brandwein, Joseph
    Jiang, Xiaoyan
    Uludag, Hasan
    BLOOD, 2022, 140 : 7791 - 7792
  • [39] Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
    Melat T. Gebru
    Hong-Gang Wang
    Journal of Hematology & Oncology, 13
  • [40] Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
    Gebru, Melat T.
    Wang, Hong-Gang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
12345